Topic Archives: Morgan Stanley (MS)



    To John King: my historical objection to Bio-PAth $BPTH has been its overvalution. It is no longer overvalued, but frank...

  • We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.

    More Info